Role of Positron Emission Tomography with Fludeoxyglucose F 18 in Personalization of Therapy in Patients with Lymphoma [0.03%]
氟脱氧葡萄糖F-18正电子发射断层显像在淋巴瘤治疗个体化中的作用
Anthony R Mato,Andre Goy
Anthony R Mato
The widespread availability of functional imaging in clinical practice has revolutionized the care (staging, response assessment, surveillance) of patients with lymphoma. Using positron emission tomography/computed tomography (PET/CT) with ...
Review of Clinical Applications of Fluorodeoxyglucose-PET/Computed Tomography in Pediatric Patients with Lymphoma [0.03%]
氟脱氧葡萄糖正电子发射断层扫描/X线计算机体层摄影在淋巴瘤患儿中的临床应用进展及思考
Gang Cheng,Scott R Akers,Hongming Zhuang et al.
Gang Cheng et al.
[(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging is routinely used in the initial diagnosis and response assessment during and immediately after therapy, as well as in the follow-up surveil...
The Evolving Role of Medical Imaging in Lymphoma Management: The Clinician's Perspective [0.03%]
淋巴瘤治疗中的医学影像作用变迁——临床医生的视角
Jakub Svoboda,Stephen J Schuster
Jakub Svoboda
Hodgkin and non-Hodgkin lymphomas are a heterogeneous group of hematologic neoplasms which arise from malignant lymphocytes. Imaging plays an important role in management of lymphoma patients during diagnosis, staging, and response assessme...
Juliano Julio Cerci,Lucia Zanoni,José C Meneghetti et al.
Juliano Julio Cerci et al.
Positron emission tomography (PET) is a sectional molecular imaging procedure that allows evaluation of the metabolism at a molecular and cellular level. For a PET scan, the patient is injected with a radiotracer, such as (18)F-fluorodeoxyg...
Thomas C Kwee,Rutger A J Nievelstein,Drew A Torigian
Thomas C Kwee
The lymphomas, Hodgkin lymphoma and non-Hodgkin lymphoma, are among the most common types of cancer in the United States. Imaging plays an important role in the evaluation of patients with lymphoma, because it aids in treatment planning and...
Hossein Jadvar
Hossein Jadvar
Neha Vapiwala,Alexander Lin
Neha Vapiwala
PET imaging has become an integral component of the diagnosis and management of a substantial number of lymphatic and solid malignancies. One of the greatest dilemmas in prostate cancer remains the need for greater personalization of treatm...
Eric M Rohren,Homer A Macapinlac
Eric M Rohren
There are significant limitations in the current options for imaging of patients with prostate carcinoma. Although fluorodeoxyglucose is the mainstay of clinical imaging, many other isotope and tracer combinations can be imaged with PET. On...
Mohsen Beheshti,Werner Langsteger
Mohsen Beheshti
Although PET using fludeoxyglucose F 18 (FDG) is a promising modality for metabolic imaging of different tumors, the results in prostate cancer have been somewhat inconsistent. Low FDG avidity of most prostate cancer cells and urinary activ...
Ekta Gupta,Drew A Torigian
Ekta Gupta
This article discusses MR imaging of the normal prostate and of disease conditions of the prostate including prostatitis, cystic lesions, amyloidosis, calculi, hematospermia, benign prostatic hyperplasia, and malignancy.